Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]

  • Kim, J. H.; 
  • Shin, S. J.; 
  • Bae, W. K.; 
  • Kim, S. H.; 
  • Kim, J. Y.; 
  • ... Kim, D.; 
  • 외 14명
Citations

WEB OF SCIENCE

1
제목
Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]
저자
Kim, J. H.; Shin, S. J.; Bae, W. K.; Kim, S. H.; Kim, J. Y.; Im, H-S.; Kim, I-H.; Kim, I-H.; Park, K.; Kim, E.; Choi, M.; Lim, J. H.; Kim, H.; Kim, H-J.; Jo, J.; Lee, H. J.; Kim, D.; Sohn, B. S.; Park, I.; Park, J. H.
DOI
10.1016/j.annonc.2024.08.1805
발행일
2024-09
유형
Meeting Abstract
저널명
Annals of Oncology
권
35
호
S2
페이지
S1026 ~ S1026